Skip to main content
See every side of every news story
Published loading...Updated

Zymeworks Strengthens Board of Directors with Appointments of Greg Ciongoli and Robert E. Landry - Zymeworks (NASDAQ:ZYME)

GREATER VANCOUVER, BRITISH COLUMBIA, AUG 11 – Greg Ciongoli and Robert E. Landry join Zymeworks' Board to support clinical development and strategic growth during a key period with multiple regulatory approvals, CEO said.

Summary by Benzinga
VANCOUVER, British Columbia, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (NASDAQ:ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced the appointments of Greg Ciongoli and Robert E. Landry to the Company's Board of Directors, effective August…

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

WellandTribune.ca broke the news in on Monday, August 11, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal